Find a Doctor

Federica D. Grosso

Ss Antonio E Biagio General Hospital
Female

Bio


Federica Grosso is in Alessandria, Italy. They have been an author on 90 peer reviewed articles and participated in 1 clinical trial in the past 15 years.

Contact

Alessandria, 15121, IT

Latest Research


Latest Advance
Study
  • Condition: Malignant Pleural Mesothelioma
  • Journal: Annals of oncology : official journal of the European Society for Medical Oncology
  • Treatment Used: Lurbinectedin
  • Number of Patients: 42
  • Published —
In this study, researchers evaluated the effects of lurbinectedin as second- or third-line palliative therapy for malignant pleural mesothelioma.
Latest Advance
Study
  • Condition: Unresectable malignant pleural mesothelioma
  • Journal: The Lancet. Oncology
  • Treatment Used: Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin
  • Number of Patients: 80
  • Published —
The study measured using tumour treating fields (an alternating use of electrical waves place around the region of a tumor) in combination with pemetrexed and cisplatin or carboplatin for unresectable malignant pleural mesothelioma.
Latest Advance
Study
  • Condition: Advanced Perivascular Epithelioid Cell Tumors (PEComas)
  • Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
  • Treatment Used: Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors
  • Number of Patients: 53
  • Published —
This study clarified the activity of conventional chemotherapy and biological agents in advanced/metastatic perivascular epitheliod cell tumors (PEComas).
Latest Advance
Study
  • Condition: Chemotherapy-Naive Patients with Advanced Malignant Pleural Mesothelioma
  • Journal: The Lancet. Respiratory medicine
  • Treatment Used: Nintedanib in Combination with Pemetrexed and Cisplatin
  • Number of Patients: 541
  • Published —
This study investigated the effectiveness and safety of pemetrexed plus cisplatin combined with nintedanib or placebo in unresectable malignant pleural mesothelioma.

All Publications
View All


Publication
Study
  • Journal: Cancers
  • Published —
DNA Methylation of FKBP5 as Predictor of Overall Survival in Malignant Pleural Mesothelioma.
Publication
Conference
  • Sponsor: European Society for Medical Oncology (ESMO)
  • Event Name: European Society for Medical Oncology Congress 2020
  • Published —
RAMES trial: A multicentre, double-blind, randomized, phase II study on gemcitabine plus ramucirumab versus gemcitabine alone as second-line treatment for advanced malignant pleural mesothelioma (MPM)

Contact

Alessandria, 15121, IT

Insurance

Contact them to find out if they accept your insurance plan.